Advertisement

Topics

Medivir: MIV-711 Osteoarthritis Trial: Recommendation to Go Ahead Based on Independent Review ...

22:07 EDT 22 Sep 2016 | BioMedReports - Blog
Medivir AB
Richard Bethell, CSO
mobile +46 (0)72-704 3211
or
Ola Burmark, CFO
mobile: +46 (0) 725 480 580

Read more...

Original Article: Medivir: MIV-711 Osteoarthritis Trial: Recommendation to Go Ahead Based on Independent Review ...

NEXT ARTICLE

More From BioPortfolio on "Medivir: MIV-711 Osteoarthritis Trial: Recommendation to Go Ahead Based on Independent Review ..."

Quick Search
Advertisement